Blasts 10 Percent or More of Bone Marrow Nucleated Cells
4 clinical trials · Condition
◉ Watch Blasts 10 Percent or More of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML (NCT04220684) | Sumithira Vasu | 2020-06-11 |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers (NCT03589729) | M.D. Anderson Cancer Center | 2018-09-19 |
| Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms (NCT02756572) | University of Washington | 2016-09-22 |
| Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia (NCT02115295) | M.D. Anderson Cancer Center | 2014-05-19 |
Track Blasts 10 Percent or More of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.